Switch to:
More From Other Websites
Asterias Biotherapeutics Named as a "Top Advanced Therapies Projects to Watch" and Will Present at... Nov 19 2014
BIOTIME INC Financials Nov 15 2014
BIOTIME INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Nov 10 2014
Asterias Biotherapeutics Reports Third Quarter Financial and Operating Results Nov 10 2014
Asterias Biotherapeutics Reports Third Quarter Financial and Operating Results Nov 10 2014
BioTime Reports Third Quarter Results and Recent Progress Nov 10 2014
BIOTIME INC Files SEC form 10-Q, Quarterly Report Nov 07 2014
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Nov 04 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia™ in Europe Nov 04 2014
BioTime Receives Authorization to Begin Pivotal Human Clinical Trial of Renevia™ in Europe Nov 04 2014
BioTime’s Subsidiary Cell Cure Neurosciences Receives FDA Authorization to Initiate Phase I/IIa... Nov 03 2014
BIOTIME INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 03 2014
BioTime’s Subsidiary Cell Cure Neurosciences Receives FDA Authorization to Initiate Phase I/IIa... Nov 03 2014
Asterias Biotherapeutics to Report Third Quarter Results on November 10, 2014 Oct 31 2014
BIOTIME INC Files SEC form 8-K, Entry into a Material Definitive Agreement Oct 22 2014
Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of... Oct 20 2014
Bloomberg Advantage: ING’s Brzeski, BioTime CEO, Mayor Warren Oct 10 2014
BIOTIME INC Files SEC form 8-K, Regulation FD Disclosure Oct 09 2014
BioTime, Inc. Closes $31 Million Financing Oct 09 2014
Asterias Biotherapeutics to List its Series A Common Stock on NYSE MKT Oct 06 2014


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK